Heat biologics, inc. (HTBX)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash Flows from Operating Activities
Net loss

-20,939

-20,384

-22,222

-19,815

-18,882

-16,591

0

0

0

-

-

-11,757

-11,481

-12,974

-16,195

-19,959

-21,829

-21,121

-18,091

-15,791

-13,846

-12,243

-10,626

-9,528

-8,244

-6,609

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Goodwill impairment loss

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncash lease expense

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncash interest expense

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash investor relations expense

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash consideration for rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Stock-based compensation

2,157

3,269

3,068

2,723

2,477

788

795

798

812

689

668

643

619

582

988

1,128

1,346

1,573

1,389

1,355

1,335

1,066

916

886

714

571

0

0

0

Depreciation

-

-

-

-

-

-

204

175

145

134

134

133

132

132

129

126

122

115

109

99

90

67

45

26

7

6

0

0

0

Amortization of deferred financing costs and debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

218

102

102

102

101

99

88

63

38

13

24

27

28

0

0

0

Amortization of held to maturity investment premium

-

-

-

-

-

-

-

-

-

-

-

-

-

32

72

115

146

142

0

0

0

-

-

-

-

-

-

-

-

Amortization of bond premium

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

115

50

0

0

0

Change in fair value of common stock warrants

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

-84

-49

65

30

0

0

0

Change in fair value of contingent consideration

472

613

558

171

599

495

890

775

235

224

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain on investments

-34

5

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash arising from changes in assets and liabilities:
Accounts receivable

65

6

-30

63

74

14

67

4

3

-67

1

9

1

82

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Stock subscription receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Prepaid expenses and other current assets

-277

-540

-1,740

-3,322

-838

-1,000

546

3,737

1,380

1,624

1,320

-166

-362

-532

-387

-379

-451

32

272

172

253

-203

-52

167

697

1,008

0

0

0

Deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

50

0

0

0

-

-

-

-

-

-

-

-

Related party receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28

24

23

19

30

15

0

0

0

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-24

0

0

0

Deferred financing costs

-

-

-

-

-

-30

-46

0

40

30

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-422

529

970

1,160

-79

-55

-235

-185

49

-175

-200

-369

-753

-1,690

-458

-310

703

642

302

77

433

716

287

-401

-483

146

0

0

0

Deferred revenue

2,168

2,377

-3,090

-4,930

-5,733

-5,793

2,352

3,721

6,273

7,026

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other liabilities

389

8

-168

-269

-607

-595

537

743

639

806

12

-560

-741

-542

-1,249

-70

769

1,040

1,620

848

346

303

288

108

208

373

0

0

0

Other long-term liabilities

-246

-213

117

137

100

53

-261

-283

-260

-300

10

42

162

311

427

384

259

149

0

0

0

-

-

-

-

-

-

-

-

Deposits

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-25

-22

-43

-32

11

0

0

0

Net Cash Used in Operating Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-18,129

-17,927

-17,447

0

0

0

-

-

-

-

-

-

-

-

Net Cash Used in Operating Activities

-14,442

-12,837

-18,583

-18,175

-22,083

-21,711

-12,607

-12,654

-7,240

-6,402

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-8,275

-6,388

0

0

0

Cash Flows from Investing Activities
Proceeds from maturities of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

6,656

6,670

8,646

11,947

14,956

19,739

21,959

25,952

18,624

13,827

9,631

482

0

0

0

0

Purchase of short-term investments

128

138

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

11,090

14,505

19,134

20,116

12,199

26,131

20,653

17,347

17,347

0

0

0

Purchase of property and equipment

250

265

0

0

0

-

-

513

474

61

61

17

20

45

54

55

138

115

113

114

462

459

496

497

54

49

0

0

0

Proceeds from disposal of property and equipment

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash (Used in) Provided by Investing Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,741

8,636

3,751

0

0

0

-

-

-

-

-

-

-

-

Net Cash Used in Investing Activities

-267

-293

-5,867

-5,814

-5,825

-6,163

-547

-513

-943

-530

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-16,919

-17,397

0

0

0

Cash Flows from Financing Activities
Proceeds from public offering of common stock and warrants, net of issuance costs

0

-

-

-

-

-

-

-

-

6,629

4,183

4,183

4,183

6,287

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

Borrowings on line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments on notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments on line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Issuance of convertible notes payable, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from the issuance of common stock, net of underwriting discounts and commissions

0

-

-

-

-

3,910

3,866

3,574

3,679

2,463

6,518

9,544

9,440

7,082

0

0

0

-

-

-

0

-

0

0

0

-

-

-

0

Proceeds from issuance of long term debt, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments on long term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

6,941

4,332

2,171

1,364

558

0

0

0

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

37

91

91

90

54

0

0

0

Stock issuance costs

0

-

-

-

-

3,130

2,142

2,134

283

324

340

537

512

488

387

190

222

302

302

302

270

0

2

798

815

944

0

0

0

Repayments on principal of finance lease

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash Provided by Financing Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,153

9,171

15,011

0

0

0

-

-

-

-

-

-

-

-

Net Cash Provided by Financing Activities

0

-

-

-

-

40,118

29,709

29,426

5,842

8,768

0

0

0

-

-

-

-

-

-

-

-

-

-

-

22,996

28,348

0

0

0

Effect of exchange rate changes on cash and cash equivalents

0

-

-

-

0

-

-

-

-

-

-

-

-

12

-117

-101

-175

-89

-67

-16

3

0

0

0

0

-

-

-

-

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Change in Cash and Cash Equivalents

2,841

-13,114

-11,627

-10,833

8,933

12,388

16,671

16,313

-2,267

1,821

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net Increase in Cash and Cash Equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

2,902

253

-4,336

-295

1,225

4,928

5,467

7,580

-853

-20,296

2,967

-2,199

4,561

0

0

0

Supplemental Disclosure for Cash Flow Information:
Operating lease right-of-use assets obtained with lease liabilities

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance lease right-of-use assets obtained with lease liabilities

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

372

322

262

281

130

82

32

17

43

55

60

0

0

0

Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Allocation of proceeds from public offering to warrant liabilities

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cashless exercise of warrants classified as liabilities

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cashless exchange of warrants classified as liabilities

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cancellation of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Non-cash consideration for rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Non-cash consideration for rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Non-cash conversion of preferred stock into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Beneficial conversion charge

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Notes payable converted to Series A preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Conversion of convertible note payable to accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Preferred conversion of preferred stock into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cashless exercise of stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Issuance of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0